Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole M Kettner

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Progress in Molecular Biology and Translational Science|August 1, 2013
The circadian clock in cancer development and therapyLoning Fu, Nicole M Kettner
Annals of Medicine|June 6, 2014
Circadian gene variants in cancerNicole M Kettner, Chinenye A Katchy, Loning Fu
Cell Metabolism|July 14, 2015
Circadian Dysfunction Induces Leptin Resistance in MiceNicole M Kettner, Sara A Mayo, Jack Hua, et al.
Molecular Endocrinology (Baltimore, Md.)|July 19, 2016
Small Heterodimer Partner (NR0B2) Coordinates Nutrient Signaling and the Circadian Clock in MiceNan Wu, Kang Ho Kim, Ying Zhou, et al.
Cancer Cell|November 28, 2016
Circadian Homeostasis of Liver Metabolism Suppresses HepatocarcinogenesisNicole M Kettner, Horatio Voicu, Milton J Finegold, et al.
International Journal of Cancer|February 8, 2022
Palbociclib plus endocrine therapy significantly enhances overall survival of HR+/HER2- metastatic breast cancer patients compared to endocrine therapy alone in the second-line setting: A large institutional studyMin Jin Ha, Akshara Singareeka Raghavendra, Nicole M Kettner, et al.
Journal of Biological Rhythms|July 20, 2016
Genetic and Environmental Models of Circadian Disruption Link SRC-2 Function to Hepatic PathologyTiffany Fleet, Erin Stashi, Bokai Zhu, et al.
NPJ Breast Cancer|January 26, 2025
Phase I trial of hydroxychloroquine to enhance palbociclib and letrozole efficacy in ER+/HER2- breast cancerAkshara Singareeka Raghavendra, Nicole M Kettner, Danielle Kwiatkowski, et al.
Molecular Cancer|February 15, 2025
Single-cell RNA sequencing identifies molecular biomarkers predicting late progression to CDK4/6 inhibition in patients with HR+/HER2- metastatic breast cancerLinjie Luo, Peng Yang, Sofia Mastoraki, et al.
Cancer Research|June 29, 2023
Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor-Positive Metastatic Breast CancersJuliana Navarro-Yepes, Nicole M Kettner, Xiayu Rao, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Progress in Molecular Biology and Translational Science|August 1, 2013
The circadian clock in cancer development and therapyLoning Fu, Nicole M Kettner
Annals of Medicine|June 6, 2014
Circadian gene variants in cancerNicole M Kettner, Chinenye A Katchy, Loning Fu
Cell Metabolism|July 14, 2015
Circadian Dysfunction Induces Leptin Resistance in MiceNicole M Kettner, Sara A Mayo, Jack Hua, et al.
Molecular Endocrinology (Baltimore, Md.)|July 19, 2016
Small Heterodimer Partner (NR0B2) Coordinates Nutrient Signaling and the Circadian Clock in MiceNan Wu, Kang Ho Kim, Ying Zhou, et al.
Cancer Cell|November 28, 2016
Circadian Homeostasis of Liver Metabolism Suppresses HepatocarcinogenesisNicole M Kettner, Horatio Voicu, Milton J Finegold, et al.
International Journal of Cancer|February 8, 2022
Palbociclib plus endocrine therapy significantly enhances overall survival of HR+/HER2- metastatic breast cancer patients compared to endocrine therapy alone in the second-line setting: A large institutional studyMin Jin Ha, Akshara Singareeka Raghavendra, Nicole M Kettner, et al.
Journal of Biological Rhythms|July 20, 2016
Genetic and Environmental Models of Circadian Disruption Link SRC-2 Function to Hepatic PathologyTiffany Fleet, Erin Stashi, Bokai Zhu, et al.
NPJ Breast Cancer|January 26, 2025
Phase I trial of hydroxychloroquine to enhance palbociclib and letrozole efficacy in ER+/HER2- breast cancerAkshara Singareeka Raghavendra, Nicole M Kettner, Danielle Kwiatkowski, et al.
Molecular Cancer|February 15, 2025
Single-cell RNA sequencing identifies molecular biomarkers predicting late progression to CDK4/6 inhibition in patients with HR+/HER2- metastatic breast cancerLinjie Luo, Peng Yang, Sofia Mastoraki, et al.
Cancer Research|June 29, 2023
Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor-Positive Metastatic Breast CancersJuliana Navarro-Yepes, Nicole M Kettner, Xiayu Rao, et al.
Pageof 2